Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05132504
Title Neoadjuvant Folfirinox Combined With Pembrolizumab Followed by Surgery for Patients With Resectable Pancreatic Cancer
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Baylor College of Medicine
Indications

pancreatic adenocarcinoma

Therapies

Fluorouracil + Irinotecan + Leucovorin + Oxaliplatin + Pembrolizumab

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.